Mélissa Bowerman

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy

Suzan M. Hammond, Gareth Hazell, Fazel Shabanpoor et al. · Proceedings of the National Academy of Sciences · 2016 · 192 citations · Full text

Glucose metabolism and pancreatic defects in spinal muscular atrophy

Mélissa Bowerman, Kathryn J. Swoboda, John‐Paul Michalski et al. · Annals of Neurology · 2012 · 179 citations · Full text

Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model

Mélissa Bowerman, Ariane Beauvais, Carrie L. Anderson et al. · Human Molecular Genetics · 2010 · 169 citations · Full text

A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology

Mélissa Bowerman, Lyndsay M. Murray, Ariane Beauvais et al. · Neuromuscular Disorders · 2011 · 143 citations

Neuromuscular Junction, Spinal Cord Injury, Medicine +9

Smn Depletion Alters Profilin II Expression and Leads to Upregulation of the RhoA/ROCK Pathway and Defects in Neuronal Integrity

Mélissa Bowerman, Dina Shafey, Rashmi Kothary · Journal of Molecular Neuroscience · 2007 · 130 citations

Neuronal Integrity, Molecular Neuroscience, Neurophysiology +9